421 related articles for article (PubMed ID: 21880869)
1. Oleuropein aglycone, an olive oil compound, ameliorates development of arthritis caused by injection of collagen type II in mice.
Impellizzeri D; Esposito E; Mazzon E; Paterniti I; Di Paola R; Morittu VM; Procopio A; Britti D; Cuzzocrea S
J Pharmacol Exp Ther; 2011 Dec; 339(3):859-69. PubMed ID: 21880869
[TBL] [Abstract][Full Text] [Related]
2. CGS 21680, an agonist of the adenosine (A2A) receptor, reduces progression of murine type II collagen-induced arthritis.
Mazzon E; Esposito E; Impellizzeri D; DI Paola R; Melani A; Bramanti P; Pedata F; Cuzzocrea S
J Rheumatol; 2011 Oct; 38(10):2119-29. PubMed ID: 21765105
[TBL] [Abstract][Full Text] [Related]
3. Reduction in the evolution of murine type II collagen-induced arthritis by treatment with rosiglitazone, a ligand of the peroxisome proliferator-activated receptor gamma.
Cuzzocrea S; Mazzon E; Dugo L; Patel NS; Serraino I; Di Paola R; Genovese T; Britti D; De Maio M; Caputi AP; Thiemermann C
Arthritis Rheum; 2003 Dec; 48(12):3544-56. PubMed ID: 14674008
[TBL] [Abstract][Full Text] [Related]
4. Erythropoietin reduces the degree of arthritis caused by type II collagen in the mouse.
Cuzzocrea S; Mazzon E; di Paola R; Genovese T; Patel NS; Britti D; de Majo M; Caputi AP; Thiemermann C
Arthritis Rheum; 2005 Mar; 52(3):940-50. PubMed ID: 15751086
[TBL] [Abstract][Full Text] [Related]
5. Absence of endogeneous interleukin-10 enhances the evolution of murine type-II collagen-induced arthritis.
Cuzzocrea S; Mazzon E; Dugo L; Serraino I; Britti D; De Maio M; Caputi AP
Eur Cytokine Netw; 2001; 12(4):568-80. PubMed ID: 11781183
[TBL] [Abstract][Full Text] [Related]
6. Type II collagen-induced arthritis in the diabetic-resistant biobreeding rat: inflammatory and histopathological features of joint pathology and effects of antiinflammatory and antirheumatic drugs on this chronic arthritic process.
Smith RJ; Sly LM
J Pharmacol Exp Ther; 1996 Jun; 277(3):1801-13. PubMed ID: 8667252
[TBL] [Abstract][Full Text] [Related]
7. Protection against cartilage and bone destruction by systemic interleukin-4 treatment in established murine type II collagen-induced arthritis.
Joosten LA; Lubberts E; Helsen MM; Saxne T; Coenen-de Roo CJ; Heinegård D; van den Berg WB
Arthritis Res; 1999; 1(1):81-91. PubMed ID: 11056663
[TBL] [Abstract][Full Text] [Related]
8. Ethyl pyruvate therapy attenuates experimental severe arthritis caused by type II collagen (CII) in the mouse (CIA).
Di Paola R; Mazzon E; Galuppo M; Esposito E; Bramanti P; Fink MP; Cuzzocrea S
Int J Immunopathol Pharmacol; 2010; 23(4):1087-98. PubMed ID: 21244758
[TBL] [Abstract][Full Text] [Related]
9. Palmitoylethanolamide and luteolin ameliorate development of arthritis caused by injection of collagen type II in mice.
Impellizzeri D; Esposito E; Di Paola R; Ahmad A; Campolo M; Peli A; Morittu VM; Britti D; Cuzzocrea S
Arthritis Res Ther; 2013; 15(6):R192. PubMed ID: 24246048
[TBL] [Abstract][Full Text] [Related]
10. Beneficial effects of tempol, a membrane-permeable radical scavenger, in a rodent model of collagen-induced arthritis.
Cuzzocrea S; McDonald MC; Mota-Filipe H; Mazzon E; Costantino G; Britti D; Mazzullo G; Caputi AP; Thiemermann C
Arthritis Rheum; 2000 Feb; 43(2):320-8. PubMed ID: 10693871
[TBL] [Abstract][Full Text] [Related]
11. Cloricromene, a coumarine derivative, protects against collagen-induced arthritis in Lewis rats.
Cuzzocrea S; Mazzon E; Bevilaqua C; Costantino G; Britti D; Mazzullo G; De Sarro A; Caputi AP
Br J Pharmacol; 2000 Dec; 131(7):1399-407. PubMed ID: 11090113
[TBL] [Abstract][Full Text] [Related]
12. Effects of combination M40403 and dexamethasone therapy on joint disease in a rat model of collagen-induced arthritis.
Cuzzocrea S; Mazzon E; Paola RD; Genovese T; Muià C; Caputi AP; Salvemini D
Arthritis Rheum; 2005 Jun; 52(6):1929-40. PubMed ID: 15934059
[TBL] [Abstract][Full Text] [Related]
13. Amelioration of joint disease in a rat model of collagen-induced arthritis by M40403, a superoxide dismutase mimetic.
Salvemini D; Mazzon E; Dugo L; Serraino I; De Sarro A; Caputi AP; Cuzzocrea S
Arthritis Rheum; 2001 Dec; 44(12):2909-21. PubMed ID: 11762952
[TBL] [Abstract][Full Text] [Related]
14. Glycogen synthase kinase-3beta inhibition attenuates the degree of arthritis caused by type II collagen in the mouse.
Cuzzocrea S; Mazzon E; Di Paola R; Muià C; Crisafulli C; Dugo L; Collin M; Britti D; Caputi AP; Thiemermann C
Clin Immunol; 2006 Jul; 120(1):57-67. PubMed ID: 16631408
[TBL] [Abstract][Full Text] [Related]
15. Beneficial effects of GW274150, a novel, potent and selective inhibitor of iNOS activity, in a rodent model of collagen-induced arthritis.
Cuzzocrea S; Chatterjee PK; Mazzon E; McDonald MC; Dugo L; Di Paola R; Serraino I; Britti D; Caputi AP; Thiemermann C
Eur J Pharmacol; 2002 Oct; 453(1):119-29. PubMed ID: 12393067
[TBL] [Abstract][Full Text] [Related]
16. High doses of interleukin-12 inhibit the development of joint disease in DBA/1 mice immunized with type II collagen in complete Freund's adjuvant.
Hess H; Gately MK; Rüde E; Schmitt E; Szeliga J; Germann T
Eur J Immunol; 1996 Jan; 26(1):187-91. PubMed ID: 8566065
[TBL] [Abstract][Full Text] [Related]
17. Mucosal-associated invariant T cells promote inflammation and exacerbate disease in murine models of arthritis.
Chiba A; Tajima R; Tomi C; Miyazaki Y; Yamamura T; Miyake S
Arthritis Rheum; 2012 Jan; 64(1):153-61. PubMed ID: 21904999
[TBL] [Abstract][Full Text] [Related]
18. Longterm protection of mice against collagen-induced arthritis after short-term LF 15-0195 treatment: modulation of B and T lymphocyte activation.
Ducoroy P; de Fornel D; Dubrez-Daloz L; Solary E; Dutartre P
J Rheumatol; 2003 May; 30(5):918-25. PubMed ID: 12734883
[TBL] [Abstract][Full Text] [Related]
19. Effects and mechanisms of total glucosides of paeony on joint damage in rat collagen-induced arthritis.
Zhu L; Wei W; Zheng YQ; Jia XY
Inflamm Res; 2005 May; 54(5):211-20. PubMed ID: 15953993
[TBL] [Abstract][Full Text] [Related]
20. Extract of the dried heartwood of Caesalpinia sappan L. attenuates collagen-induced arthritis.
Wang YZ; Sun SQ; Zhou YB
J Ethnopharmacol; 2011 Jun; 136(1):271-8. PubMed ID: 21557995
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
